(Q44896647)

7 December 2017

title

Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis (English)

1 reference

7 December 2017

1 reference

P Hadji

1

1 reference

7 December 2017

V Ziller

2

1 reference

7 December 2017

J Kyvernitakis

3

1 reference

7 December 2017

M Bauer

4

1 reference

7 December 2017

G Haas

5

1 reference

7 December 2017

N Schmidt

6

1 reference

7 December 2017

K Kostev

7

1 reference

7 December 2017

language of work or name

English

0 references

publication date

20 January 2013

1 reference

Breast Cancer Research and Treatment

7 December 2017

published in

1 reference

7 December 2017

volume

138

1 reference

7 December 2017

issue

1

1 reference

7 December 2017

page(s)

185-191

1 reference

Estimates of cancer incidence and mortality in Europe in 2008.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Adherence to therapy with oral antineoplastic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Menopausal symptoms and adjuvant therapy-associated adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Methods for evaluation of medication adherence and persistence using automated databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Adherence beliefs among breast cancer patients taking tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

21 January 2018

Medical Record Databases

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Early discontinuation of tamoxifen: a lesson for oncologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Factors affecting discontinuation of alendronate treatment in postmenopausal Japanese women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2417-1

10.1007/S10549-013-2417-1

21 January 2018

Identifiers

DOI

1 reference

release_u3pwzf4tdrcupjuf6sgwga7tkq

7 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/u3pwzf4tdrcupjuf6sgwga7tkq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference